Results 141 to 150 of about 189,322 (291)

ChatGPT Versus DeepSeek in Resectability Categorization of Chronic Rhinosinusitis: A Comparison Based on EPOS 2020

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To evaluate and compare the performance of ChatGPT‐5.5 (2026) and DeepSeek‐V3 (2026) in classifying CRS resectability according to the EPOS 2020 guidelines, employing various prompting strategies. Methods In this retrospective study, 150 chronic rhinosinusitis cases were reviewed, and three rhinology experts classified resectability ...
Jia‐Hong Lao, Shu‐Yi Huang, Fei‐Tong Jian, Rong‐Rong Ge, Yu Jiang, Xue‐Kun Huang, Zhao‐Hui Shi, Qin‐Tai Yang, Shuo Wu   +8 more
wiley   +1 more source

A Rare Case of Nasal Glial Heterotopia Presenting as Sphenochoanal Polyp*

, 2015
Objective: This paper reports a rare case of nasal glial heterotopia presenting as sphenochoanal polyp. So far, literature has revealed only few cases.
Pavol Surda, Jonathan Hobson
core  

Treatment Persistence and Factors Associated With Discontinuation in Real‐World Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Biologic therapies are effective for severe, uncontrolled CRSwNP, yet real‐world data on treatment persistence remain limited. Methods This retrospective single‐center study included 95 adults with CRSwNP who initiated dupilumab (88.4%), mepolizumab, or omalizumab between 2021 and 2025.
Hen Chaushu, Yuval Presman, Roni Vass, Narin Nard Carmel‐Neiderman, Liyona Kampel, Forsan Jahashan, Nidal Muhanna, Eiman Abu Bandora, Avraham Abergel   +8 more
wiley   +1 more source

Nasal polyps. [PDF]

BMJ, 1973
  +6 more sources

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo‐Controlled, Phase III Trial

Allergy, EarlyView.
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian, Menglin Wang, Changqing Zhao, Lijia Wan, Yu Xu, Juan Meng, Rui Xu, Xicheng Song, Li Shi, Yucheng Yang, Yan Jiang, Yanzhen Wu, Bethany Ling, Vivian Li, Andrew P. Fontenot, Lacey R. Robinson, Neelam A. Phadke, Chengshuo Wang, Luo Zhang   +18 more
wiley   +1 more source

Multi-Omics Analysis Reveals Abnormal Metabolism of Lysophosphatidylinositol in Nasal Polyp. [PDF]

Allergy Asthma Immunol Res
Lie J, Xu Z, Zhang H, Liu X, Dang H, Zou H, Tian P, Zhong H, Ma Y.   +8 more
europepmc   +1 more source

Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial

Allergy, EarlyView.
Both Full and Limited FESS result in clinically meaningful relief of disease‐specific HRQoL and nasal breathing, effectively improving nasal symptoms and sleep disturbance in CRSwNP patients. Clinically meaningful difference in decrease of SNOT‐22 scores between the groups was not found at 12‐ and 24–month follow‐up.
P. Virkkula, S. Hammarén‐Malmi, A. Laulajainen‐Hongisto, M. Lilja, J. Wikstén, L. Hafrén, P. Kauppi, S. Reitsma, K. Pajala, J. Sahlman, S. Toppila‐Salmi   +10 more
wiley   +1 more source

Nasal polyp with ossification in the right maxillary sinus: Differential diagnosis of radiopaque lesions in maxillary sinus region. [PDF]

J Dent Sci
Li SL, Chou SJ, Wu YC, Ho CY.
europepmc   +1 more source

Revisiting Nasal Polyp Scoring in Clinical Trials: Interpretive Variability and the Need for Standardization. [PDF]

Int Forum Allergy Rhinol
Sowerby LJ, Pourmomenarabi B, Maniaci A, Ginty O, Han JK.   +4 more
europepmc   +1 more source

Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres, Cristobalina Mayorga, Elizabeth J. Phillips, Adriana Ariza, Annick Barbaud, Patrizia Bonadonna, Mariana Castells, Gülfem Çelik, Knut Brockow, Lene H. Garvey, Inmaculada Doña, Jean‐Christoph Caubet, Francesca Mori, Jason Trubiano, Giorgia Marta, Antonino Romano, Ingrid Terreehorst, Asli Gelincik, Philip H. Li, Vito Sabato   +19 more
wiley   +1 more source